Skip to content
OpenCapital
Get started

Revolve Group RVLV Share-Based Payment - Unrecognized Cost of Nonvested Awards

Share-Based Payment - Unrecognized Cost of Nonvested Awards at other companies

Ryan Specialty Holdings logo
Ryan Specialty HoldingsRYAN
$223.55M+9.5%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$19.87-29.9%
GitLab logo
GitLabGTLB
$700K-95.8%
Open Text logo
Open TextOTEX
$125.81M-15.8%
MarketAxess logo
MarketAxessMKTX
$70.9M+3.2%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$84.1M—

Other financials

Income statement

See full
Revenue$342.9M+15.6%
Gross profit$180.6M+17.1%
Operating income$15.7M+6.6%
Net income$14.4M+21.4%
EPS (diluted)$0.20+25.0%

Balance sheet

See full
Cash & equivalents$335.8M+11.6%
Total debt$33.4M-25.0%
Total equity$405.8M-0.1%
Total assets$821.4M+15.1%

Cash flow

See full
Operating cash flow$49.4M+9.5%
CapEx$5.0M+178%
Free cash flow$44.5M+2.5%

Valuation

See full
Market cap$1.64B+12.7%
Enterprise value$1.34B+11.5%
P/E25.6×-3.3×
P/S1.3×0.0×

Profitability

See full
Gross margin53.6%+1.2pp
Operating margin5.9%+1.0pp
Net margin5.1%+0.7pp
FCF margin5.3%—

Returns & leverage

See full
Return on equity8.1%-2.7pp
Debt / equity0.1×0.0×
Current ratio2.5×-0.1×

Questions, answered.

What does share-based payment - unrecognized cost of nonvested awards mean?
This represents the total compensation expense for equity-based awards that has been granted but not yet recognized in the income statement because the vesting conditions have not been met. It serves as a forward-looking indicator of future non-cash compensation expenses. Investors use this to forecast the impact of stock-based compensation on future earnings.